Sprout AI (CSE: BYFM), a technologically focused, sustainable vertical farming company, has developed scalable, AI-controlled aeroponic cultivation habitats and technology that provides solutions to the ever-increasing complexities surrounding current and future needs of a sustainable global food production and supply chain. As referenced in its Oct. 21 press release, the company confirms that it is not aware of any material,…
2021 brought the largest cannabis sales day ever, the first-ever comprehensive cannabis reform bills, new markets, new opportunities, and so much more DENVER, Jan. 25, 2022 /PRNewswire/ — Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announced the release of its annual Cannabis Industry…
Depression, or more formally Major Depressive Disorder (MDD), is a widespread and growing problem across the globe. In the United States in 2019, 19.4 million adults (7.8% of all adults) were estimated to have a major depressive episode. About two-thirds of these people received treatment of some sort, and the most effective treatments produce roughly 30 to 40 percent remission rates. As a…
Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industry DehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic…
VANCOUVER, BC, Dec. 20, 2021 /PRNewswire/ – Xebra Brands Ltd. (“Xebra”) (CSE: XBRA) (OTC: XBRAF) (FSE: 9YC), a cannabis company, reports that it has received significant news coverage by Mexican and international Tier 1 media, since the December 2nd announcement that it has received an injunction from the Mexican Supreme Court, granting it an outright first-mover advantage in the Mexican CBD and CBG industry. Xebra…
RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT…
Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, is moving toward new growth initiatives and expanding organically, according to a recent corporate update. The company noted that the expansion was organic, within the framework of its primary operating vision. Currently, Sugarmade operates a Nug Avenue location in Los Angeles, which has seen significant…
Last week, Rep. Nancy Mace, who introduced a measure to federally legalize cannabis, revealed that she had used the herb in her youth as a substitute for her depression medication after she was raped. The Republican Congresswoman revealed in an interview on Fox Business that she was raped when she was 16, explaining that the prescribed medications to deal with…
BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has released its unaudited financial results for the quarter ended Sept. 30, 2021; all numbers are in Canadian dollars. Among the highlights include a revenue growth figure of $1.1 million, which represents more than a 1,000% increase over the $94,000 reported…
Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the…
RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations, upcoming events, and a Q&A session A replay of the call will be available for 90 days, starting three hours after the conclusion RWB is…
InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together…